Forum for Science, Industry and Business

Air travelers with cardiovascular disease remain safe - with some recommendations

A review article by Yale researchers reaffirms that the vast majority of people with cardiovascular disease can travel safely on airlines, provided they follow basic guidelines such as carrying an ample supply of medication or waiting two weeks to travel after having a cardiac procedure.

Published in the July 20 issue of Annals of Internal Medicine, the article reviewed previous studies on air travel and cardiovascular disease. "We pulled together work that has been done on the topic, synthesized the findings and created evidence-based guidelines," said first author Stephen E. Possick, M.D., a cardiology fellow at Yale School of Medicine. "While other guidelines exist, ours detail both the reasons those with cardiovascular disease might be at increased risk and the data that support the safety of airline travel in most travelers with cardiovascular disease."

Concern about air travel by cardiovascular patients exists because altitude can decrease the oxygen content in blood and impair the breakdown of blood clots, potentially leading to complications. Currently there are few medical incidents on airlines: about eight medical incidents per one million flights, according to Possick. Of these incidents, 19.4 percent were cardiac related.

Karen N. Peart | EurekAlert!
Further information:
http://www.yale.edu

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

Im Focus: Like a wedge in a hinge

Researchers lay groundwork to tailor drugs for new targets in cancer therapy

In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...